J. Valle

An in Situ Atlas of Mitochondrial DNA in Mammalian Tissues Reveals High Content in Stem and Proliferative Compartments

J. Hicks, A. Marzo, S. Yegnasubramanian, 2020 .

Phase III results of exatecan (DX-8951f) versus gemcitabine (Gem) in chemotherapy-naïve patients with advanced pancreatic cancer (APC).

H. Friess, Y. Humblet, G. Bodoky, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Use of Aspirin and Statins in Relation to Inflammation in Benign Prostate Tissue in the Placebo Arm of the Prostate Cancer Prevention Trial

Jun O. Liu, I. Thompson, P. Goodman, 2020, Cancer Prevention Research.

Neoadjuvant randomized trial of degarelix (Deg) ± cyclophosphamide/GVAX (Cy/GVAX) in men with high-risk prostate cancer (PCa) undergoing radical prostatectomy (RP).

A. Partin, C. Drake, M. Allaf, 2017 .

Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer.

T. Hickish, A. Norman, M. Nicolson, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adult Urology Oncology: Prostate/Testis/Penis/Urethra JU Insight Cell Cycle Progression Score, but Not Phosphatase and Tensin Homolog Loss, Is an Independent Prognostic Factor for Metastasis in Intermediate- and High-risk Prostate Cancer in Men Treated With and Without Salvage Radiotherapy

A. Partin, Misop Han, S. Stone, 2022 .